Charles L. Vogel
- Oncology top 0.05%
- Radiology, Nuclear Medicine and Imaging top 0.1%
- Cancer Research top 0.2%
- Molecular Biology top 2%
- Pulmonary and Respiratory Medicine top 0.5%
- Co-authors
- Melody CobleighDennis J. SlamonLouis FehrenbacherDebu TripathySteven ShakJanet WolterNicholas J. RobertVirginia Paton
- Topics
- Cancer Treatment and Pharmacology (67 papers)HER2/EGFR in Cancer Research (52 papers)Breast Cancer Treatment Studies (45 papers)
- Partner nations
- United StatesUgandaUnited Kingdom
In The Last Decade
Charles L. Vogel
160 papers receiving 16.0k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Oncology 11.4k
- Radiology, Nuclear Medicine and Imaging 4.4k
- Cancer Research 3.6k
- Molecular Biology 3.6k
- Pulmonary and Respiratory Medicine 2.7k
Countries citing papers authored by Charles L. Vogel
This map shows the geographic impact of Charles L. Vogel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles L. Vogel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles L. Vogel more than expected).
Fields of papers citing papers by Charles L. Vogel
This network shows the impact of papers produced by Charles L. Vogel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles L. Vogel. The network helps show where Charles L. Vogel may publish in the future.
Co-authorship network of co-authors of Charles L. Vogel
This figure shows the co-authorship network connecting the top 25 collaborators of Charles L. Vogel. A scholar is included among the top collaborators of Charles L. Vogel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles L. Vogel. Charles L. Vogel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 2 | |
| 3 | 17 | |
| 4 | A phase 2, randomized, open-label study of lucitanib in patients with FGF aberrant metastatic breast cancer. | 2 |
| 5 | 47 | |
| 6 | 198 | |
| 7 | 407 | |
| 8 | 150 | |
| 9 | 84 | |
| 10 | 21 | |
| 11 | Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancerbreakdown → | 1508 |
| 12 | Estrogen receptor status in the Herceptin (trastuzumab) clinical trials: Incidence and relation to clinical benefit | 2 |
| 13 | 145 | |
| 14 | 0 | |
| 15 | 87 | |
| 16 | Adjuvant systemic therapy of primary breast cancer | 24 |
| 17 | Maximizing differences in the concanavalin A-induced blastogenic responses of lymphocytes from breast cancer patients and controls by the use of alpha-methyl-D-mannoside. | 0 |
| 18 | [Dental injuries during general anaesthesia and their forensic consequences (author's transl)]. | 11 |
| 19 | 40 | |
| 20 | 33 |
About Charles L. Vogel
Charles L. Vogel is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 163 papers that have together received 16.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (67 papers), HER2/EGFR in Cancer Research (52 papers) and Breast Cancer Treatment Studies (45 papers). The work is most often cited by research in Oncology (11.4k citations), Cancer Research (3.6k citations) and Radiology, Nuclear Medicine and Imaging (4.4k citations). Charles L. Vogel has collaborated with scholars based in United States, Uganda and United Kingdom. Frequent co-authors include Melody Cobleigh, Dennis J. Slamon, Louis Fehrenbacher, Debu Tripathy, Steven Shak, Janet Wolter, Nicholas J. Robert, Virginia Paton, Suzy Scholl and Vincent T. DeVita. Their work appears in journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.